Pittenger & Anderson Inc’s Aurinia Pharmaceuticals AUPH Stock Holding History

Pittenger & Anderson Inc’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17K	Hold	1,000	–	–	﹤0.01%	377
2026 Q1	$14.8K	Hold	1,000	–	–	﹤0.01%	383
2025 Q4	$15.9K	Hold	1,000	–	–	﹤0.01%	379
2025 Q3	$11.1K	Sell	1,000 -1,000	-50%	-$10.9K	﹤0.01%	361
2025 Q2	$16.9K	Buy	2,000 +1,000	+100%	+$8.02K	﹤0.01%	338
2025 Q1	$8.04K	Hold	1,000	–	–	﹤0.01%	364
2024 Q4	$8.98K	Hold	1,000	–	–	﹤0.01%	367
2024 Q3	$7.33K	Hold	1,000	–	–	﹤0.01%	385
2024 Q2	$5.71K	Hold	1,000	–	–	﹤0.01%	395
2024 Q1	$5.01K	Hold	1,000	–	–	﹤0.01%	388
2023 Q4	$8.99K	Hold	1,000	–	–	﹤0.01%	374
2023 Q3	$7.77K	Hold	1,000	–	–	﹤0.01%	361
2023 Q2	$9.68K	Hold	1,000	–	–	﹤0.01%	363
2023 Q1	$11K	Hold	1,000	–	–	﹤0.01%	348
2022 Q4	$4.32K	Hold	1,000	–	–	﹤0.01%	387
2022 Q3	$8K	Hold	1,000	–	–	﹤0.01%	349
2022 Q2	$10K	Hold	1,000	–	–	﹤0.01%	341
2022 Q1	$12K	Hold	1,000	–	–	﹤0.01%	341
2021 Q4	$23K	Hold	1,000	–	–	﹤0.01%	304
2021 Q3	$22K	Hold	1,000	–	–	﹤0.01%	314
2021 Q2	$13K	Hold	1,000	–	–	﹤0.01%	320
2021 Q1	$13K	Hold	1,000	–	–	﹤0.01%	310
2020 Q4	$14K	Buy	+1,000	New	+$14.6K	﹤0.01%	300

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pittenger & Anderson Inc's AUPH Position: Q2 2026 in Review

Pittenger & Anderson Inc held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 1,000 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #377.

Pittenger & Anderson Inc first reported a position in AUPH in Q4 2020 and has held it in 23 quarters since. The position peaked at $23K in Q4 2021. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Pittenger & Anderson Inc held 1,000 shares of Aurinia Pharmaceuticals worth $17K as of Q2 2026.
Pittenger & Anderson Inc left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #377 holding.
Pittenger & Anderson Inc first reported a position in Aurinia Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
Pittenger & Anderson Inc's Aurinia Pharmaceuticals position peaked at $23K in Q4 2021.
281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.